Wednesday, May 14th
1:00PM – 2:00PM ET
Virtual Webinar
The Lung-MAP Accrual Enhancement Committee (AEC) is hosting an upcoming public webinar titled, Advocating, Accelerating, and Amplifying Lung Cancer Discovery. The webinar will feature experts from the current Lung-MAP clinical trial to discuss recent trial updates, challenges to the traditional clinical trial landscape that Lung-MAP is working to overcome, and opportunities for patient engagement in the process. The event will feature a panel discussion among lung cancer advocates with their perspectives on these topics.
Lung-MAP is a cancer clinical trial designed to quickly and efficiently test new treatments for advanced non-small cell lung cancers – which make up about 85 percent of all lung cancer diagnoses in the United States. Lung-MAP is offered at hospitals and clinics country wide, making it easier for patients to participate and get access to investigational treatments to fight their lung cancer.
Click the link above to register. The agenda is forthcoming.
Lung-MAP is a groundbreaking public-private partnership that includes the NCI and its National Clinical Trials Network (NCTN) including SWOG Cancer Research Network, Friends of Cancer Research (Friends), the Foundation for the National Institutes of Health (FNIH), Foundation Medicine, pharmaceutical companies which provided their drugs for the study, and several lung cancer advocacy organizations.
